RXO, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by RXO, Inc. on October 22, 2024. The filing addresses a specific corporate event regarding the resale of common stock by certain selling stockholders under a previously filed registration statement (Form S-3ASR, File No. 333-282002).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding securities registration and does not contain financial performance data.
Material Changes
The material event reported is the filing of a prospectus supplement covering the resale of an aggregate of 28,514,952 shares of the Company's common stock. This total consists of:
- 22,255,481 shares of common stock currently outstanding.
- 6,259,471 shares of common stock issuable upon the exercise of pre-funded warrants.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It does not disclose new risks or contingencies beyond the standard disclosure of the stock resale process. A legal opinion regarding the shares was filed as Exhibit 5.1.
Investor Verification Checklist
- Verify the identity of the "certain selling stockholders" named in the prospectus supplement to assess potential dilution impact.
- Review the full prospectus supplement (File No. 333-282002) for details on the offering price and underwriting arrangements.
- Confirm the current trading volume and market price of RXO common stock on the New York Stock Exchange to gauge market reaction to the resale.
- Check subsequent filings for the actual execution of the sale and the number of shares ultimately sold.